Promomed has launched the first-in-class drug Amberwin® Pulmo with a unique mechanism of action and high efficacy in improving lung health in a wide range of diseases. It is a bioregulator from the class of short peptides, created on the company's own technology platform. Active ingredient of the drug is a synthetic peptide of six amino acids combined with a fragment of succinic acid.